Navigation Links
Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
Date:4/2/2013

ve Intelligence and Drug Safety & Pharmacovigilance solutions. At the 2012 Bio-IT World Conference Cambridge Semantics’ Competitive Intelligence Solution was named “Best of Show” for its unique approach to helping pharma companies handle their diverse and ever-changing information needs. The company’s Drug Safety & Pharmacovigilance solution helps pharma reduce operational cost and improve risk management by automating and streamlining the process of discovering, managing, and analyzing adverse drug reactions.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10589552.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
2. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
3. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
4. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
5. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
6. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
7. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
8. Clinverse CEO to Speak at MAGI East 2013
9. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
10. iLuv Introducing NFC & Qi-Certified Technology to Bluetooth Speaker Lineup at 2013 CES
11. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... provider of strategic communications services to corporations and organizations preparing for ... United States and Europe , today ... to the firm,s Washington, D.C. office. ... years of service as Associate Commissioner for the Office of External ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo announced ... from the National Institutes of Health (NIH) to help ... effective treatments to patients on a faster timeline. Organovo ... Sciences (NCATS) and the National Eye Institute (NEI) to ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... Highlights Trends In eCTD Migration And Submissions Outsourcing And, Provides ... ... America And Europe, PHILADELPHIA and LONDON, July 17 ... its 2008,Liquent Regulatory Affairs Trends Survey. The survey attracted respondents,from across ...
... Johnson & Johnson Pharmaceutical,Research & Development, L.L.C. ... (FDA) Anti-Infective Drugs Advisory Committee voted in,favor of ... for,injection) for the treatment of hospital-acquired pneumonia, or ... committee voted that 500 mg of DORIBAX at ...
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today ... Sankyo), has received marketing,approval from the Japanese Ministry ... extension of Biopten(R) (sapropterin dihydrochloride), which,contains the same ... the,treatment of patients with phenylketonuria (PKU). BioMarin will ...
Cached Biology Technology:The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results 2The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results 3FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 2FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 3FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 4Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 2Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 3Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 4
(Date:7/9/2014)... are turning to more healthful alternatives to their savored ... mean low satisfaction. Now researchers are reporting new progress ... are made with olive oil rather than pork fat. ... Agricultural and Food Chemistry . , Ana M. Herrero ... expect just the right amount of chewiness and springiness, ...
(Date:7/9/2014)... census of Adlie penguins shows that the population ... larger than previously estimated. Adlie penguins have long ... and understand the effects of climate change and ... high-resolution satellite imagery, researchers from Stony Brook University ... method that permits regular monitoring of Adlie penguins ...
(Date:7/9/2014)... economy driven by methane, the primary component of natural gas, ... boom. It has poised the country as a top fuel ... just how climate-friendly it is, according to an article in ... magazine of the American Chemical Society. , In the article, ... burned as a fuel to produce electricity, methane emits about ...
Breaking Biology News(10 mins):New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3
... (FDA) today approved Symlin, an injectable medicine to control blood ... Symlin is to be used in addition to insulin therapy ... sugars on intensive insulin therapy alone. , Symlin will be ... other than insulin. Patients with type 2 diabetes already have ...
... of Liverpool have discovered how fish have evolved over ... different water depths. , A research team led by ... of Biological Sciences, has revealed how modern fish, such ... floating at certain water levels using a gas-filled swimbladder. ...
... Genomed-Health 2005 workshop in Tunisia, supported by the ... sciences in improving health in countries bordering the ... the importance of Euro-Mediterranean partnerships in order to ... ?in particular following the mapping of the human ...
Cached Biology News:FDA Approves New Drug to Treat Type I and Type II Diabetes 2Scientists discover how fish evolved to float at different sea depths 2Measuring the impact of post-genomics on Mediterranean populations 2
... Clone/PAD: ZMD.330. Immunogen: Synthetic peptide derived ... rat and mouse protein kinase C zeta ... rat and mouse PKCzeta protein. Recognizes ... not cross-react with PKCiota/lambda. Reactivity: Mouse ...
Lipid-rich bovine serum albumin for cell culture. It is chromatographically purified and has an IgG content 1.0% (w/w)....
Request Info...
... Immunogen KLH-conjugated, ... acids 47-66 (PAEV-GPGAVGERTPRKKEPP) of human ... 1 (BHC110/LSD1). Quality Assurance ... Stability 2 ...
Biology Products: